课题基金 / 基金详情

Use of double negative regulatory T cell to induce tolerogenic dendritic cells and CD4+Foxp3+ regulatory T cells to develop donor-specific transplantation tolerance.

Use of double negative regulatory T cell to induce tolerogenic dendritic cells and CD4+Foxp3+ regulatory T cells to develop donor-specific transplantation tolerance.
使用双阴性调节性 T 细胞诱导耐受性树突状细胞和 CD4 Foxp3 调节性 T 细胞以产生供体特异性移植耐受性。
批准号:
279435
负责人:
Lee Jong Bok
金额:
$1.27万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-02-01 至 2014-02-01

项目摘要

项目成果

Lee Jong Bok的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Transplantation can save lives of people suffering from end-stage organ failure. Current therapy involves injection of immunosuppressive drugs to transplant recipients to prevent destruction of donated organs by recipients' immune system through a proces
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
  • 批准号:
    488039
  • 项目类别:
    Operating Grants
  • 资助金额:
    $73.84万
  • 财政年份:
    2023
  • 负责人:
    Lee Jong Bok
  • 依托单位:
Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
  • 批准号:
    493332
  • 项目类别:
  • 资助金额:
    $0.22万
  • 财政年份:
    2023
  • 负责人:
    Lee Jong Bok
  • 依托单位:
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
  • 批准号:
    498857
  • 项目类别:
    Operating Grants
  • 资助金额:
    $1.82万
  • 财政年份:
    2023
  • 负责人:
    Lee Jong Bok
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    481581
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    2022
  • 负责人:
    Lee Jong Bok
  • 依托单位:
海外基金